WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced it has been recognized by Scrip Intelligence with its 2012 award for Best Technological Development in Clinical Trials for deploying cutting-edge solutions advancing clinical research. PPD received the honor at the annual Scrip Awards ceremony Nov. 28 in London, marking the second consecutive year PPD won for best technology after receiving the 2011 Scrip Award for Best Contract Research Organization (CRO). “Winning this award for the second consecutive year is a testament to the people of PPD,” said David Simmons, chairman and CEO of PPD. “In today’s evolving health care model, CROs must be able to adapt to clients’ changing needs and proactively meet their challenges. PPD connects talented people and innovative solutions to exceed the needs of our biopharmaceutical industry clients, who are constantly seeking ways to increase productivity and efficiency.”
